Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway 英文参考文献.docVIP

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway 英文参考文献.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway 英文参考文献

SclerostinStimulatesOsteocyteSupportofOsteoclast ActivitybyaRANKL-DependentPathway AsiriR.Wijenayaka1,MasakazuKogawa1,HuiPengLim1,LyndaF.Bonewald2,DavidM.Findlay1, GeraldJ.Atkins1* 1BoneCellBiologyGroup,DisciplineofOrthopaedicsandTrauma,UniversityofAdelaide,andtheHansonInstitute,Adelaide,Australia,2UniversityofMissouri-Kansas CitySchoolofDentistry,DepartmentofOralBiology,KansasCity,Missouri,UnitedStatesofAmerica Abstract Sclerostinisaproductofmatureosteocytesembeddedinmineralisedboneandisanegativeregulatorofbonemassand osteoblastdifferentiation.Whileevidencesuggeststhatsclerostinhasananti-anabolicrole,thepossibilityalsoexiststhat sclerostin has catabolic activity. To test this we treated human primary pre-osteocyte cultures, cells we have found are exquisitely sensitive to sclerostin, or mouse osteocyte-like MLO-Y4 cells, with recombinant human sclerostin (rhSCL) and measuredeffectsonpro-catabolicgeneexpression.Sclerostindose-dependentlyup-regulatedtheexpressionofreceptor activatorofnuclearfactorkappaB(RANKL)mRNAanddown-regulatedthatofosteoprotegerin(OPG)mRNA,causingan increase in the RANKL:OPG mRNA ratio. To examine the effects of rhSCL on resulting osteoclastic activity, MLO-Y4 cells plated onto a bone-like substrate were primed with rhSCL for 3 days and then either mouse splenocytes or human peripheral blood mononuclear cells (PBMC) were added. This resulted in cultures with elevated osteoclastic resorption (approximately 7-fold) compared to untreated co-cultures. The increased resorption was abolished by co-addition of recombinantOPG.Inco-culturesofMLO-Y4cellswithPBMC,SCLalsoincreasedthenumberandsizeoftheTRAP-positive multinucleatedcellsformed.Importantly,rhSCLhadnoeffectonTRAP-positivecellformationfrommonoculturesofeither splenocytesorPBMC.Further,rhSCLdidnotinduceapoptosisofMLO-Y4cells,asdeterminedbycaspaseactivityassays, demonstrating that the osteoclastic response was not driven by dying osteocytes. Together, these results suggest that sclerostinmayhaveaca

您可能关注的文档

文档评论(0)

1234554321 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档